Abstract
On the first anniversary of Vanda, 1) to what extent have legal arguments and claim amendments based on Vanda been effective in overcoming 35 USC 101 Mayo-based rejections?; and 2) How are applicants transforming diagnostic patent claims into method of treatment claims to overcome Mayo-based subject matter eligibility rejections?
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Nature Biotechnology |
| Vol/bind | 38 |
| Sider (fra-til) | 279–283 |
| Antal sider | 5 |
| ISSN | 1087-0156 |
| DOI | |
| Status | Udgivet - 2020 |
Emneord
- Det Juridiske Fakultet